• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将非中脑神经干细胞向多巴胺能神经元分化。

Differentiation of non-mesencephalic neural stem cells towards dopaminergic neurons.

机构信息

Department of Neuroscience, University Medical Center Groningen, University of Groningen, A. Deusinglaan 1, 9713AV Groningen, The Netherlands.

出版信息

Neuroscience. 2010 Oct 13;170(2):417-28. doi: 10.1016/j.neuroscience.2010.07.023. Epub 2010 Jul 17.

DOI:10.1016/j.neuroscience.2010.07.023
PMID:20643196
Abstract

Neural stem cells (NSCs), either isolated from fetal or adult human brain or derived from induced pluripotent stem cells, are now considered major candidates for in vitro generation of transplantable dopaminergic (DA) neurons and modeling of Parkinson's disease. It is generally thought that in vitro differentiation of neural stem cells into meso-diencephalic dopaminergic neurons, requires recapitulation of dopaminergic differentiation pathway normally occurring in the ventral mesencephalon during embryogenesis. This dopaminergic pathway is partially activated by a combination of the extracellular induction factors Sonic Hedgehog (Shh), Fibroblast Growth Factor 8 (FGF8) and Wnt1 that trigger specific intracellular transcription cascades. In vitro mimicking of these embryonic ventral mesencephalic conditions has been successful for dopaminergic differentiation of embryonic stem cells and ventral mesencephalic NSCs. Dopaminergic differentiation of non-mesencephalic NSCs (nmNSCs), however, is considered arduous. Here we examine whether Shh, FGF8 and Wnt1 can activate typical dopaminergic transcription factors, such as Lmx1a, Msx1 and Otx2 in nmNSCs. We found that Shh, FGF8 and Wnt1 induced the expression of Lmx1a and Otx2 in nmNSCs resulting in the differentiation of up to 39% of the nmNSCs into neurons expressing Pitx3. However, only a low number ( approximately 13%) of these cells became more DA-like neurons also expressing tyrosine hydroxylase (TH). The histone deacetylase (HDAC)-inhibitor trichostatin A combined with Shh, FGF8 and Wnt1 caused orchestrated induction of Lmx1a, Otx2, Msx1 plus the early DA transcription factor En1. Now significantly increased numbers of TH ( approximately 22%) and Pitx3 ( approximately 33%) neurons were observed. Most of these cells coexpressed the DA markers DAT and Vmat2. Taken together, we demonstrate that nmNSCs indeed can be differentiated towards DA-like neurons, but this differentiation is far from complete in comparison to ventral mesencephalic NSCs and embryonic stem cells; most likely, the nmNSCs lack the proper "primed" epigenetic state of these cells for DA differentiation facilitating the induction of DA specific transcription factors.

摘要

神经干细胞(NSCs),无论是从胎儿或成人脑中分离出来的,还是从诱导多能干细胞中衍生出来的,现在都被认为是体外生成可移植的多巴胺能(DA)神经元和模拟帕金森病的主要候选者。一般认为,体外将神经干细胞分化为中脑多巴胺能神经元,需要重现胚胎发育过程中中脑腹侧多巴胺能分化途径。这个多巴胺能途径部分被 Sonic Hedgehog(Shh)、Fibroblast Growth Factor 8(FGF8)和 Wnt1 等细胞外诱导因子的组合激活,这些因子触发特定的细胞内转录级联反应。体外模拟这些胚胎腹侧中脑条件已经成功地用于胚胎干细胞和腹侧中脑 NSCs 的多巴胺能分化。然而,非中脑 NSCs(nmNSCs)的多巴胺能分化被认为是困难的。在这里,我们研究了 Shh、FGF8 和 Wnt1 是否可以在 nmNSCs 中激活典型的多巴胺能转录因子,如 Lmx1a、Msx1 和 Otx2。我们发现,Shh、FGF8 和 Wnt1 诱导 nmNSCs 表达 Lmx1a 和 Otx2,导致高达 39%的 nmNSCs 分化为表达 Pitx3 的神经元。然而,只有少数(约 13%)这些细胞成为更多的多巴胺能神经元,也表达酪氨酸羟化酶(TH)。组蛋白去乙酰化酶(HDAC)抑制剂 Trichostatin A 与 Shh、FGF8 和 Wnt1 联合使用,导致 Lmx1a、Otx2、Msx1 和早期 DA 转录因子 En1 的协调诱导。现在观察到显著增加数量的 TH(约 22%)和 Pitx3(约 33%)神经元。这些细胞中的大多数共同表达 DA 标志物 DAT 和 Vmat2。总之,我们证明了 nmNSCs 确实可以分化为多巴胺能样神经元,但与腹侧中脑 NSCs 和胚胎干细胞相比,这种分化还远远不够;很可能,nmNSCs 缺乏这些细胞进行 DA 分化的适当“启动”表观遗传状态,从而促进 DA 特异性转录因子的诱导。

相似文献

1
Differentiation of non-mesencephalic neural stem cells towards dopaminergic neurons.将非中脑神经干细胞向多巴胺能神经元分化。
Neuroscience. 2010 Oct 13;170(2):417-28. doi: 10.1016/j.neuroscience.2010.07.023. Epub 2010 Jul 17.
2
Transforming growth factor beta is required for differentiation of mouse mesencephalic progenitors into dopaminergic neurons in vitro and in vivo: ectopic induction in dorsal mesencephalon.转化生长因子β是小鼠中脑祖细胞在体外和体内分化为多巴胺能神经元所必需的:在中脑背侧的异位诱导
Stem Cells. 2006 Sep;24(9):2120-9. doi: 10.1634/stemcells.2005-0514. Epub 2006 Jun 1.
3
Fibroblast growth factor-20 promotes the differentiation of Nurr1-overexpressing neural stem cells into tyrosine hydroxylase-positive neurons.成纤维细胞生长因子-20促进过表达Nurr1的神经干细胞分化为酪氨酸羟化酶阳性神经元。
Neurobiol Dis. 2004 Nov;17(2):163-70. doi: 10.1016/j.nbd.2004.07.007.
4
Sonic hedgehog and FGF8: inadequate signals for the differentiation of a dopamine phenotype in mouse and human neurons in culture.音猬因子和FGF8:在培养的小鼠和人类神经元中,不足以诱导多巴胺表型分化的信号
Exp Neurol. 2001 May;169(1):36-43. doi: 10.1006/exnr.2001.7640.
5
Permanent expression of midbrain dopaminergic neurons traits in differentiated amniotic epithelial cells.在分化的羊膜上皮细胞中永久表达中脑多巴胺能神经元特征。
Neurosci Lett. 2012 Jan 6;506(1):22-7. doi: 10.1016/j.neulet.2011.10.038. Epub 2011 Oct 21.
6
Lmx1a allows context-specific isolation of progenitors of GABAergic or dopaminergic neurons during neural differentiation of embryonic stem cells.Lmx1a 允许胚胎干细胞神经分化过程中 GABA 能或多巴胺能神经元祖细胞的特异性分离。
Stem Cells. 2012 Jul;30(7):1349-61. doi: 10.1002/stem.1105.
7
Differentiation of dopaminergic neurons from human embryonic stem cells: modulation of differentiation by FGF-20.人胚胎干细胞向多巴胺能神经元的分化:FGF-20对分化的调节作用
J Biosci Bioeng. 2009 Apr;107(4):447-54. doi: 10.1016/j.jbiosc.2008.12.013.
8
In-vitro analysis of Pitx3 in mesodiencephalic dopaminergic neuron maturation.中脑多巴胺能神经元成熟过程中Pitx3的体外分析
Eur J Neurosci. 2009 Jun;29(12):2264-75. doi: 10.1111/j.1460-9568.2009.06784.x. Epub 2009 Jun 8.
9
Enhanced proliferation and dopaminergic differentiation of ventral mesencephalic precursor cells by synergistic effect of FGF2 and reduced oxygen tension.碱性成纤维细胞生长因子 2 和低氧张力协同作用增强腹侧中脑神经前体细胞的增殖和多巴胺能分化。
Exp Cell Res. 2011 Jul 15;317(12):1649-62. doi: 10.1016/j.yexcr.2011.04.012. Epub 2011 May 3.
10
Generation and properties of a new human ventral mesencephalic neural stem cell line.一种新型人腹侧中脑神经干细胞系的生成及特性
Exp Cell Res. 2009 Jul 1;315(11):1860-74. doi: 10.1016/j.yexcr.2009.03.011. Epub 2009 Mar 24.

引用本文的文献

1
Directional induction of neural stem cells, a new therapy for neurodegenerative diseases and ischemic stroke.神经干细胞的定向诱导,一种治疗神经退行性疾病和缺血性中风的新疗法。
Cell Death Discov. 2023 Jul 1;9(1):215. doi: 10.1038/s41420-023-01532-9.
2
Harnessing the HDAC-histone deacetylase enzymes, inhibitors and how these can be utilised in tissue engineering.利用 HDAC-组蛋白去乙酰化酶酶、抑制剂以及如何将它们应用于组织工程。
Int J Oral Sci. 2019 Jun 10;11(2):20. doi: 10.1038/s41368-019-0053-2.
3
Sequential Application of Discrete Topographical Patterns Enhances Derivation of Functional Mesencephalic Dopaminergic Neurons from Human Induced Pluripotent Stem Cells.
连续应用离散拓扑模式可增强人诱导多能干细胞衍生功能性中脑多巴胺能神经元的能力。
Sci Rep. 2018 Jun 22;8(1):9567. doi: 10.1038/s41598-018-27653-1.
4
Suppression of histone deacetylation promotes the differentiation of human pluripotent stem cells towards neural progenitor cells.组蛋白去乙酰化的抑制促进人多能干细胞向神经祖细胞的分化。
BMC Biol. 2014 Nov 19;12:95. doi: 10.1186/s12915-014-0095-z.
5
Class-IIa Histone Deacetylase Inhibition Promotes the Growth of Neural Processes and Protects Them Against Neurotoxic Insult.IIa类组蛋白去乙酰化酶抑制作用促进神经突起生长并保护其免受神经毒性损伤。
Mol Neurobiol. 2015;51(3):1432-42. doi: 10.1007/s12035-014-8820-8. Epub 2014 Jul 29.
6
Strategies to modulate heritable epigenetic defects in cellular machinery: lessons from nature.调节细胞机制中遗传表观遗传缺陷的策略:来自大自然的启示。
Pharmaceuticals (Basel). 2012 Dec 27;6(1):1-24. doi: 10.3390/ph6010001.
7
Engraftment of mouse embryonic stem cells differentiated by default leads to neuroprotection, behaviour revival and astrogliosis in parkinsonian rats.胚胎干细胞在默认情况下分化的移植会导致帕金森病大鼠的神经保护、行为恢复和星形胶质细胞增生。
PLoS One. 2013 Sep 12;8(9):e72501. doi: 10.1371/journal.pone.0072501. eCollection 2013.
8
Histone deacetylase inhibitors in cell pluripotency, differentiation, and reprogramming.组蛋白去乙酰化酶抑制剂在细胞多能性、分化和重编程中的作用。
Stem Cells Int. 2012;2012:184154. doi: 10.1155/2012/184154. Epub 2012 Mar 8.
9
Induced pluripotent stem cell technology and direct conversion: new possibilities to study and treat Parkinson's disease.诱导多能干细胞技术和直接转化:研究和治疗帕金森病的新可能。
Stem Cell Rev Rep. 2013 Aug;9(4):505-13. doi: 10.1007/s12015-012-9369-4.
10
Clinical application of stem cell therapy in Parkinson's disease.干细胞治疗在帕金森病中的临床应用。
BMC Med. 2012 Jan 4;10:1. doi: 10.1186/1741-7015-10-1.